Showing results (41-50 of 107) with videos related to
Sort By:
Pageof 11
International Journal of Clinical Oncology|October 12, 2007
Superior vena cava syndrome caused by supraclavicular lymph node metastasis of renal cell carcinomaMizuaki Sakura, Toshihiko Tsujii, Akimasa Yamauchi, et al.The Journal of Urology|January 20, 2009
Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C scoreYasumasa Iimura, Kazutaka Saito, Yasuhisa Fujii, et al.European Urology|April 7, 2007
Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomyShinya Yamamoto, Junji Yonese, Satoru Kawakami, et al.Anticancer Research|January 2, 2016
Efficacy and Safety Profile of Enzalutamide for Japanese Patients with Castration-resistant Prostate CancerMutsushi Yamasaki, Takeshi Yuasa, Shinya Yamamoto, et al.Chemotherapy|July 26, 2014
First-line combination chemotherapy with cisplatin, etoposide and ifosfamide for the treatment of disseminated germ cell cancer: re-evaluation in the granulocyte colony-stimulating factor eraHajime Tanaka, Takeshi Yuasa, Yasuhisa Fujii, et al.Urologia Internationalis|November 14, 2012
Evaluation of the RENAL nephrometry scoring system in adopting nephron-sparing surgery for cT1 renal cancerYosuke Yasuda, Takeshi Yuasa, Shinya Yamamoto, et al.International Journal of Clinical Oncology|July 4, 2015
Clinical outcome of urachal cancer in Japanese patientsTatsuro Hayashi, Takeshi Yuasa, Sho Uehara, et al.Japanese Journal of Clinical Oncology|April 28, 2009
Risk stratification of high-grade prostate cancer treated with antegrade radical prostatectomy with intended wide resectionShinya Yamamoto, Satoru Kawakami, Junji Yonese, et al.International Journal of Clinical Oncology|August 14, 2012
Prognostic impact of pretreatment C-reactive protein for patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitorsYosuke Yasuda, Kazutaka Saito, Takeshi Yuasa, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 17, 2013
Longitudinal change in health-related quality of life after intensity-modulated radiation monotherapy for clinically localized prostate cancerShinya Yamamoto, Yasuhisa Fujii, Hitoshi Masuda, et al.Pageof 11